According to MarketsandMarkets™, the Oligonucleotide Synthesis Market is projected to reach USD 32.72 billion by 2031 from USD 14.64 billion in 2026, at a CAGR of 17.4% during the forecast period.

Opportunities center on integrated development-to-commercial manufacturing for complex RNA medicines, including GMP scale-up, analytical/QC, regulatory support and sterile fill-finish. Demand is ...

As Chief Editor of one of the two journals in which Biopharma Dealmakers appears, I have a keen interest in the process of translating biomedical research into new drugs, including the partnerships ...

Using a short, synthetic chain of chemically modified nucleotides engineered in the RNA Therapeutics Institute at UMass Chan Medical School, Robert H. Brown Jr., DPhil, MD, Jonathan Watts, PhD, and ...

Scientists have developed a new approach to produce life-saving oligonucleotide therapeutics on a large scale, in high purity, and with minimal environmental impacts. The finding, by The University of ...

Horus’ VECTrans® platform to deliver Servier’s oligonucleotides to the brain for the treatment of rare neurological and neurodevelopmental disorders Agreement provides Servier with option to advance ...

- The next frontier in oligonucleotide synthesis is the direct synthesis of gene-length sequences. - Ansa synthesized a 1005 base long oligonucleotide with industry-leading accuracy. - Ansa will be ...

Current HILIC retention concepts insufficiently explain oligonucleotide behavior on amide phases, limiting predictability and complicating analytical optimization for closely related therapeutic ...

According to MarketsandMarkets, the Oligonucleotide Synthesis Market is projected to reach USD 32.72 billion by 2031 from USD 14.64 billion ...

Scientists have developed a new approach to produce life-saving oligonucleotide therapeutics on a large scale, in high purity, and with minimal environmental impacts. Scientists have developed a new ...